AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $232.36
-
Support level$227.21
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)54.8
- Up 6.0 percent, ABBV is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- ABBV is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
- Price crossed above 50-day moving average this week - a bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $164.99 | $244.38 | 87.2% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $202.02 | $224.82 | $224.99 | $222.46 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.5%
-
In the next month13.3%
-
In the next year56.3%
| Period | Value |
|---|---|
| Historical (5 year) | 23.1% |
| Last month | 22.1% |
| Current estimate | 23.7% |
| Next month forecast | 23.5% |